Dr. Anthonise Louis Fields is senior director of Strategic Collaboration, head of the COVID Taskforce, and leader of the BOLD Marketplace pillar at Bristol Myers Squibb (BMS). She is responsible for accelerating BMS research and priorities through collaborations with leading US Academic Institutions across all therapeutic areas (Immunology/Fibrosis, CV, Oncology and Hematology). As the head of the COVID Taskforce, Dr. Fields advanced innovative customer-centric solutions to address the rapidly changing needs of disproportionately affected communities. For three years, she has led the convening of expert oncology, hematology, and health equity leaders at annual Heme/Onc congresses to generate strategies targeting cancer disparities in vulnerable patient populations.
Prior to joining BMS, Dr. Fields was scientific integration lead at Janssen (Johnson and Johnson), where she developed analytical strategies for priority vaccine candidates. She has authored numerous articles in peer-reviewed scientific journals, presented pivotal data before the FDA, Bill and Melinda Gates Foundation, the NIH, etc. Preceding Janssen, Dr. Fields has an extensive history at Merck & Co, where she launched and managed over 10 assets across therapeutic areas.
She received her bachelor’s degree from the University of Pennsylvania, where she was a Howard Hughes Research Fellow and a Penn Women’s Trustees Scholar. She earned her PhD in microbiology and immunology from the Temple School of Medicine. She serves on the Philadelphia local Board of the American Cancer Society, served as academic advisor and on the Board of A Better Chance – Swarthmore, and is an ardent mentor who is passionate about bringing hands-on STEM experiences to kids. Anthonise lives in West Chester, Pennsylvania, with her husband Miles David and two children and is an active member of the Chester County Chapter of Jack and Jill of America, Inc.